Author:
Kekilli Murat,Tunc Bilge,Beyazit Yavuz,Kurt Mevlut,Onal Ibrahim Koral,Ulker Aysel,Haznedaroglu Ibrahim Celalettin
Publisher
Springer Science and Business Media LLC
Subject
Gastroenterology,Physiology
Reference28 articles.
1. Marelli L, Xirouchakis E, Kalambokis G, et al. Does the severity of primary sclerosing cholangitis influence the clinical course of associated ulcerative colitis? Gut. 2011;60:1224–1228.
2. Navaneethan U, Venkatesh PG, Lashner BA, et al. The impact of ulcerative colitis on the long-term outcome of patients with primary sclerosing cholangitis. Aliment Pharmacol Ther. 2012. doi: 10.1111/j.1365-2036.2012.05063.x .
3. Navaneethan U, Venkatesh PG, Mukewar S, et al. Progressive primary sclerosing cholangitis requiring liver transplantation is associated with reduced need for colectomy in patients with ulcerative colitis. Clin Gastroenterol Hepatol. 2012;10:540–546.
4. Farkas K, Nagy F, Kovacs L, et al. Ulcerative colitis and primary sclerosing cholangitis as part of autoimmune polyglandular syndrome type III. Inflamm Bowel Dis. 2010;16:10–11.
5. Eaton JE, Silveira MG, Pardi DS, et al. High-dose ursodeoxycholic acid is associated with the development of colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis. Am J Gastroenterol. 2011;106:1638–1645.
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献